[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609621":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":29,"centralContacts":34,"locations":40,"responsibleParty":98,"collaborators":100,"id":104,"slug":105,"hasResults":106,"nctId":107,"briefTitle":108,"officialTitle":109,"acronym":15,"eligibilityCriteria":110,"healthyVolunteers":106,"sex":111,"minAge":112,"maxAge":25,"enrollmentInfo":113,"targetDuration":25,"studyType":116,"phases":117,"briefSummary":119,"conditions":120,"keywords":125,"overallStatus":133,"whyStopped":25,"lastUpdateSubmitDate":134,"lastUpdatePostDateStruct":135,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":142,"locationsCount":143},{"fullName":5,"class":6},"Duke University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Community Paramedic Standard of Care (CP SOC)","ACTIVE_COMPARATOR","The community paramedic (CP) standard of care (SOC) has three basic components across all study sites. The core components of the CP SOC are that CPs: 1) are deployed via 911 as an opioid and\u002For stimulant overdose response; 2) provide Medications for Opioid Use Disorder (MOUD), harm reduction service referrals, and link patients to health and social programs as needed; and 3) provide long-term follow-up care in the field after initial contact.",[13],"Behavioral: Community Paramedic Standard of Care (CP SOC)",{"label":15,"type":16,"description":17,"interventionNames":18},"CROSSROADS","EXPERIMENTAL","The community paramedic (CP) standard of care (SOC) has three basic components across the sites. The core components of the CP SOC are that CPs: 1) are deployed via 911 as an opioid and\u002For stimulant overdose response; 2) provide Medications for Opioid Use Disorder (MOUD), harm reduction service referrals, and link patients to health and social programs as needed; and 3) provide long-term follow-up care in the field after initial contact. The CROSSROADS intervention will utilize these SOC aspects and build in technology-supported medical-legal partnerships (MLP) via Docs for Health (D4H) that identifies and addresses health-harming legal needs (HHLN). While CP SOC may refer to services that address some HHLN, the key component of the CROSSROADS intervention is the direct identification and addressing of HHLN via D4H.",[19],"Behavioral: CROSSROADS",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","Participants randomized to CP SOC will receive 1) community paramedic standard of care after initial response to overdose; 2) Medications for Opioid Use Disorder (MOUD), harm reduction referrals, and linkages to health and social programs as needed; 3) long-term follow-up care with community paramedics in the field after initial contact.",[9],null,{"type":22,"name":15,"description":27,"armGroupLabels":28,"otherNames":25},"The community paramedic (CP)standard of care (SOC) has three basic components across the sites. The core components of the CP SOC are that CPs: 1) are deployed via 911 as an opioid and\u002For stimulant overdose response; 2) provide Medications for Opioid Use Disorder (MOUD), harm reduction service referrals, and link patients to health and social programs as needed; and 3) provide long-term follow-up care in the field after initial contact. The CROSSROADS intervention will utilize these SOC aspects and build in technology-supported medical-legal partnerships (MLP) via Docs for Health (D4H) that identifies and addresses health-harming legal needs (HHLN). While CP SOC may refer to services that address some HHLN, the key component of the CROSSROADS intervention is the direct identification and addressing of HHLN via D4H.",[15],[30],{"name":31,"affiliation":32,"role":33},"Lauren Brinkley-Rubinstein, PhD","Duke Health","PRINCIPAL_INVESTIGATOR",[35],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},"Margaret Roach, MPH","CONTACT","919-660-3008","margaret.roach@duke.edu",[41,57,70,85],{"facility":42,"status":25,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"University of Miami","Miami","Florida","33146","United States","US",{"type":49,"coordinates":50},"Point",[51,52],-80.19366,25.77427,{"lat":52,"lon":51},[55],{"name":56,"role":33,"phone":25,"phoneExt":25,"email":25},"Kathryn Nowotny, PhD",{"facility":58,"status":25,"city":59,"state":60,"zip":61,"country":46,"countryCode":47,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Boston Medical Center","Boston","Massachusetts","02118",{"type":49,"coordinates":63},[64,65],-71.05977,42.35843,{"lat":65,"lon":64},[68],{"name":69,"role":33,"phone":25,"phoneExt":25,"email":25},"Alysse Wurcel, MD",{"facility":5,"status":25,"city":71,"state":72,"zip":73,"country":46,"countryCode":47,"cosmosGeoPoint":74,"geoPoint":78,"contacts":79},"Durham","North Carolina","27701",{"type":49,"coordinates":75},[76,77],-78.89862,35.99403,{"lat":77,"lon":76},[80,81,82],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},{"name":31,"role":33,"phone":25,"phoneExt":25,"email":25},{"name":83,"role":84,"phone":25,"phoneExt":25,"email":25},"Catherine Paquette, PhD","SUB_INVESTIGATOR",{"facility":86,"status":25,"city":87,"state":88,"zip":89,"country":46,"countryCode":47,"cosmosGeoPoint":90,"geoPoint":94,"contacts":95},"University of Pittsburgh","Pittsburgh","Pennsylvania","15260",{"type":49,"coordinates":91},[92,93],-79.99589,40.44062,{"lat":93,"lon":92},[96],{"name":97,"role":33,"phone":25,"phoneExt":25,"email":25},"Emily Dauria, PhD",{"type":99,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[101],{"name":102,"class":103},"National Institute on Drug Abuse (NIDA)","NIH","100609621","the-community-paramedic-response-and-overdose-outreach-with-supportive-medical-legal-services-study-100609621",false,"NCT07216963","The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study","The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services (CROSSROADS) Study","Inclusion Criteria:\n\n* 18 years old or older;\n* Has interacted with a CP team (and, thus, experienced a non-fatal opioid and\u002For stimulant overdose) in the last 30 days;\n* Has independent legal agency\n* Able to independently provide informed consent; and\n* Able to speak and understand English.\n\nExclusion Criteria:\n\n\\- Active, severe, and untreated mental illness that would make providing consent impossible","ALL","18 Years",{"count":114,"type":115},400,"ESTIMATED","INTERVENTIONAL",[118],"NA","The goal of this clinical trial is to develop and test the CROSSROADS intervention. CROSSROADS is designed for people who have recently survived an opioid and\u002For stimulant-related non-fatal overdose and had contact with staff from a Community Paramedic (CP) program.\n\nParticipants will be randomly placed into one of two groups:\n\n1\\) Standard of care from the CP program, or 2) CROSSROADS, which includes CP care plus a Medical-Legal Partnership (MLP). The MLP helps people with legal problems that can affect their health-- like issues with housing or public benefits.\n\nResearchers will test if the CROSSROADS intervention reduces drug use and involvement with the criminal legal system.\n\nPeople in the study will be followed for one year and asked to complete surveys at the beginning, and again at 1 month, 6 months, and 12 months.",[121,122,123,124],"Opioid Use Disorder","Overdose, Drug","Overdose","Substance Use (Drugs, Alcohol)",[123,126,127,128,129,130,131,132],"Community Paramedic","Medical-Legal Services","Criminal Legal System","Consolidated Framework for Implementation Research","Paramedical Personnel","Human Centered Design","Criminal Legal","NOT_YET_RECRUITING","2026-04-07",{"date":136,"type":137},"2026-04-13","ACTUAL",{"date":139,"type":115},"2026-09-01",{"date":141,"type":115},"2030-08-01",{"name":5,"class":6},4]